1. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19;Mirabelli;bioRxiv,2020
2. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs;Jeon;Antimicrob. Agents Chemother.,2020
3. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication;Touret;bioRxiv,2020
4. Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection;Ellinger;Research Square,2020
5. Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2;Heiser;bioRxiv,2020